Growth Metrics

AtriCure (ATRC) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to -$2.6 million.

  • AtriCure's Cash from Investing Activities fell 15931.24% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.6 million, marking a year-over-year decrease of 16321.87%. This contributed to the annual value of $30.2 million for FY2024, which is 3858.0% up from last year.
  • Latest data reveals that AtriCure reported Cash from Investing Activities of -$2.6 million as of Q3 2025, which was down 15931.24% from -$7.7 million recorded in Q2 2025.
  • Over the past 5 years, AtriCure's Cash from Investing Activities peaked at $63.6 million during Q1 2021, and registered a low of -$25.1 million during Q3 2021.
  • Over the past 5 years, AtriCure's median Cash from Investing Activities value was $1.1 million (recorded in 2021), while the average stood at $5.7 million.
  • Per our database at Business Quant, AtriCure's Cash from Investing Activities skyrocketed by 55013.93% in 2022 and then plummeted by 42738.69% in 2024.
  • Quarter analysis of 5 years shows AtriCure's Cash from Investing Activities stood at $1.1 million in 2021, then surged by 550.14% to $7.0 million in 2022, then crashed by 139.79% to -$2.8 million in 2023, then plummeted by 427.39% to -$14.7 million in 2024, then skyrocketed by 82.27% to -$2.6 million in 2025.
  • Its Cash from Investing Activities stands at -$2.6 million for Q3 2025, versus -$7.7 million for Q2 2025 and -$1.7 million for Q1 2025.